Lung adenocarcinoma targeted drugs

Targeted therapy is a treatment method targeting identified carcinogenic sites at the cellular molecular level. Corresponding therapeutic drugs can be designed. When drugs enter the body, they will specifically select carcinogenic sites and combine with them to cause specific death of tumor cells without affecting normal tissue cells around the tumor. Therefore, molecular targeted therapy is also called biological missiles. Currently, commonly used biological targeted drugs include gefitinib, icotinib, osimertinib, etc. The use of targeted drugs for lung adenocarcinoma requires gene detection, clear diagnosis, and selection of appropriate targeted drugs according to mutant genes and drug indications.